Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

por Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, Archary, Moherndran, Bhorat, Qasim, Fairlie, Lee, Lalloo, Umesh, Masilela, Mduduzi S. L., Moodley, Dhayendre, Hanley, Sherika, Fouche, Leon, Louw, Cheryl, Tameris, Michele, Singh, Nishanta, Goga, Ameena, Dheda, Keertan, Grobbelaar, Coert, Kruger, Gertruida, Carrim-Ganey, Nazira, Baillie, Vicky, de Oliveira, Tulio, Koen, Anthonet Lombard, Lombaard, Johan J., Mngqibisa, Rosie, Bhorat, As’ad Ebrahim, Benadé, Gabriella, Lalloo, Natasha, Pitsi, Annah, Vollgraaff, Pieter-Louis, Luabeya, Angelique, Esmail, Aliasgar, Petrick, Friedrich G., Jose, Aylin Oommen, Foulkes, Sharne, Ahmed, Khatija, Thombrayil, Asha, Fries, Lou, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S., Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M., Dubovsky, Filip, Madhi, Shabir A.
Publicado 2021

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B tr...

por Madhi, Shabir A, Moodley, Dhayendre, Hanley, Sherika, Archary, Moherndran, Hoosain, Zaheer, Lalloo, Umesh, Louw, Cheryl, Fairlie, Lee, Fouche, Leon Frederik, Masilela, Mduduzi S L, Singh, Nishanta, Grobbelaar, Coert, Ahmed, Khatija, Benadé, Gabriella, Bhikha, Sutika, Bhorat, As'ad Ebrahim, Bhorat, Qasim, Joseph, Natasha, Dheda, Keertan, Esmail, Aliasgar, Foulkes, Sharne, Goga, Ameena, Oommen Jose, Aylin, Kruger, Gertruida, Kalonji, Dishiki J, Lalloo, Natasha, Lombaard, Johan J, Lombard Koen, Anthonet, Kany Luabeya, Angelique, Mngqibisa, Rosie, Petrick, Friedrich G, Pitsi, Annah, Tameris, Michele, Thombrayil, Asha, Vollgraaff, Pieter-Louis, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S, Fries, Lou, Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M, Shinde, Vivek
Publicado 2022